JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M100715200 on July 20, 2001

J. Biol. Chem., Vol. 276, Issue 37, 34722-34727, September 14, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/37/34722    most recent
M100715200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guse, A. H.
Right arrow Articles by Mayr, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guse, A. H.
Right arrow Articles by Mayr, G. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Transient Tyrosine Phosphorylation of Human Ryanodine Receptor upon T Cell Stimulation*

Andreas H. GuseDagger §, Alexander Y. Tsygankov, Karin WeberDagger , and Georg W. MayrDagger

From the Dagger  Division of Cellular Signal Transduction, Institute for Medical Biochemistry and Molecular Biology, University of Hamburg, University Hospital Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany and the  Department of Microbiology and Immunology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140

Received for publication, January 25, 2001, and in revised form, July 10, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The ryanodine receptor of Jurkat T lymphocytes was phosphorylated on tyrosine residues upon stimulation of the cells via the T cell receptor/CD3 complex. The tyrosine phosphorylation was transient, reaching a maximum at 2 min, and rapidly declined thereafter. In co-immunoprecipitates of the ryanodine receptor, the tyrosine kinases p56lck and p59fyn were detected. However, only p59fyn associated with the ryanodine receptor in a stimulation-dependent fashion. Both tyrosine kinases, recombinantly expressed as glutathione S-transferase (GST) fusion proteins, phosphorylated the immunoprecipitated ryanodine receptor in vitro. In permeabilized Jurkat T cells, GST-p59fyn, but not GST-p56lck, GST-Grb2, or GST alone, significantly and concentration-dependently enhanced Ca2+ release by cyclic ADP-ribose. The tyrosine kinase inhibitor PP2 specifically blocked the effect of GST-p59fyn. This indicates that intracellular Ca2+ release via ryanodine receptors may be modulated by tyrosine phosphorylation during T cell activation.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Ryanodine receptors (RyR)1 are large tetrameric Ca2+ channel-forming proteins. Three different isoforms of RyR have been identified, termed types 1, 2, and 3 (also known as skeletal muscle type RyR, cardiac muscle type RyR, and brain type RyR (reviewed in Ref. 1)). There is indeed abundant expression of these particular isoforms in the respective tissues, but there is also increasing evidence for low expression of different RyR in other tissues (2).

In skeletal and cardiac muscle, RyR are the major intracellular Ca2+ release channels, which control contractility by Ca2+-induced Ca2+ release (reviewed in Ref. 3). In neuronal cells, Ca2+ release via RyR is involved in fundamental brain function, such as long term depression (4).

Ca2+ release via RyR is controlled by Ca2+ itself (5). In addition, investigations in different cell systems suggest that the cyclic nucleotide cADPR may also function as an endogenous ligand for RyR-mediated Ca2+-release (reviewed in Refs. 6 and 7).

Activation of T lymphocytes is a fundamental part of the immune system to ensure protection against foreign antigens. One of the intracellular signaling pathways essentially necessary for T cell activation is a sustained elevation of [Ca2+]i (reviewed in Ref. 8). The sustained elevation of [Ca2+]i results in activation of many proteins (reviewed in Ref. 9). Of particular interest is the protein phosphatase calcineurin, which, upon activation by Ca2+/calmodulin, dephosphorylates the transcription factor nuclear factor of activated T cells (10). Only this dephosphorylated form of nuclear factor of activated T cells can enter the nucleus to activate multiple gene expression, e.g. expression of interleukin-2 (10).

Among the first biochemical events that are observed during T cell activation is phosphorylation of multiple proteins on tyrosine residues. These phosphorylation events are mediated by a concerted action of several protein-tyrosine kinases (PTK), including Src family PTKs p56lck and p59fyn (11-14).

Recently, we have provided evidence that cADPR and RyR play an important role in the sustained phase of Ca2+ signaling in T cells (15). Since TCR/CD3 complex-mediated Tyr phosphorylation of the type 1 Ins(1,4,5)P3 receptor has been described recently (16), in this study we investigated (i) whether also RyR might be phosphorylated on tyrosine residues in a stimulation-dependent fashion, and (ii) whether such tyrosine phosphorylation might have a functional effect on Ca2+ release via RyR.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Antibodies and antisera were obtained as follows: anti-RyRcommon mouse monoclonal antibody (mAb) from Calbiochem, Eggenstein, Germany; anti-RyRcommon antiserum (no. C-18) from Santa Cruz Biotechnology, Heidelberg, Germany; anti-phosphotyrosine mAb (clone PY 99) from Santa Cruz Biotechnology; anti-phosphotyrosine antiserum (rabbit polyclonal IgG) from Upstate Biotechnology, Lake Placid, NY, obtained via Biomol, Hamburg, Germany; anti-p56lck mAb (clone 3A5) and anti-p59fyn (clone 15) both from Santa Cruz Biotechnology. The Src-type PTK inhibitor PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine; Ref. 17) was obtained from Calbiochem, Eggenstein, Germany.

All other chemicals used were of the highest purity grade available. MilliQ water (Millipore Waters, Eschborn, Germany) was used for the preparation of all buffers.

Cell Culture-- Jurkat T lymphocytes (subclone JMP) were cultured as described previously (18) in RPMI 1640 medium containing Glutamax I (Life Technologies, Eggenstein, Germany), buffered by HEPES (20 mM, pH 7.4) and supplemented with newborn calf serum (7.5%), penicillin (100 units/ml), and streptomycin (50 µg ml; all from Life Technologies). The cells were cultured at 37 °C in a humidified atmosphere in the presence of 5% CO2.

Localization of RyR by Confocal Microscopy-- The cells were fixed using 2% (w/v) p-formaldehyde in buffer A containing (mM) 140 NaCl, 5 KCl, 1 MgSO4, 1 CaCl2, 1 NaH2PO4, 5.5 glucose, and 20 HEPES (pH 7.4) for 15 min at room temperature. Then, the cells were rinsed twice with buffer A. Permeabilization was carried out by incubation in methanol for 5 min at room temperature. Afterwards, the cells were again rinsed twice with buffer A. Subsequently, the cells were incubated with anti-RyRcommon mAb (Calbiochem) at 1 µg/100 µl for 60 min at room temperature. Then, excess of mAb was removed by rinsing the cells twice with buffer A. Finally, a secondary fluorescein isothiocyanate-labeled goat anti-mouse antiserum (Molecular Probes Europe, Leiden, The Netherlands) was added at 4 µg/100 µl for 60 min at room temperature in the dark. Then, excess of the antiserum was removed by rinsing the cells twice with buffer A. Cells stained in this way were kept on ice in the dark until use (usually within the next 90 min).

Confocal microscopy was performed using a monochromator-based imaging system (Improvision, Heidelberg, Germany) built around a Leica DM IRBE microscope at 100-fold magnification. Images were taken with a 12 bit gray-scale CCD camera (type C4742-95-12NRB; Hamamatsu, Enfield, United Kingdom) on 30 consecutive horizontal (z) planes, each 0.5 µm, from the bottom to the top of the cell. The spatial resolution in the horizontal plane (xy plane) of the camera was 0.067 µm/pixel. Excitation wavelength was 485 nm, and emission light was filtered at 525 nm. Raw data images were stored on hard disk. To obtain digital confocal images, mathematical deconvolution based on the point-spread algorithm was carried out using the Openlab Confocal Imaging software module (Ref. 19; Improvision, Heidelberg, Germany). Usually, deconvolution was carried out using two or three neighbors on each side of the central horizontal plane of the cell; the magnitude setting of removal of stray light was 0.2300-0.2400 (on a scale between 0 (no removal) and 0.9999 (complete removal of stray light)).

Preparation of the Subcellular Fraction P10 from Jurkat T Lymphocytes-- The cells (109 lymphocytes) were harvested, centrifuged twice (500 × g, 5 min, room temperature), and washed twice in 5 ml of 20 mM HEPES (pH 7.5), 110 mM NaCl. Following an incubation period of 20 min at 37 °C, the cells were homogenized on ice in the presence of protease inhibitors (AEBSF, 500 µM; leupeptin, 20 µM; pepstatin, 1 µM; antipain, 10 µM) and dephostatin (100 µM) using a tight Potter-Elvehjem homogenizer (1500 units/min, 30 strokes). All further steps were carried out at 4 °C. After removal of cell debris and unbroken cells by low speed centrifugation (500 × g, 10 min), the supernatant was ultracentrifuged (20 min, 10000 × g, 4 °C) to obtain the membrane fraction P10. This fraction was stored in aliquots at -70 °C.

Protein Assay-- For protein determination the Bio-Rad protein assay (Bio-Rad, München, Germany) was used as microassay with bovine serum albumin (fraction V; Sigma, Deisenhofen, Germany) as standard.

Immunoprecipitation of RyR-- RyR from P10 membranes, known to be the major source for RyR in Jurkat T cells (15), were solubilized by addition of lysis buffer (25 mM HEPES, pH 7.2, 150 mM NaCl, 0.25% CHAPS (w/v), protease inhibitors as above). 20 µg of anti-RyRcommon mAb (Calbiochem) or anti-RyRcommon polyclonal antiserum (Santa Cruz) were coupled to Protein G-Sepharose (50 µl of a 50% (w/v) suspension) in 500 µl of lysis buffer (1.5 h, 4 °C, continuous shaking). Anti-RyRcommon coupled to Protein G-Sepharose (50 µl) was then incubated with solubilized P10 membranes (400 µg of protein) in lysis buffer for 1.5 h at 4 °C under continuous shaking. Then, the Protein G-Sepharose beads were centrifuged (13,000 × g, 1 min, 4 °C), the supernatant was discarded, and the immunoprecipitate rinsed with lysis buffer; the washing procedure was then repeated three times (for co-precipitation experiments, two times).

Western Blotting-- Immunoprecipitated RyR protein was boiled at 95 °C for 5 min and subjected to SDS-PAGE in a 6% gel (3% stacking gel) under reducing conditions. To ensure migration of the large RyR subunits (~550 kDa) into the gel, the gel run was extended for another 60 min after the bromphenol blue band had reached the end of the gel. In co-immunoprecipitation experiments, 7.5% polyacrylamide gels were used; also, in these experiments, gel runs were terminated as soon as the bromphenol blue band had reached the end of the gel.

Proteins were subsequently transferred onto nitrocellulose sheets by tank blotting (18 h, 550 mA constant, 4 °C). The nitrocellulose sheets were blocked with fatty acid-free milk powder (5% w/v in TBS buffer (1.4 M NaCl, 0.1 M Tris-HCl, pH 8.0) with 0.5% Tween 20) for 1 h at room temperature, and immunostained with the primary antibody (in TBS buffer with 0.5% Tween 20) for 18 to 24 h at 4 °C. Concentrations of the primary antibodies were: (i) anti-RyRcommon mAb, 5 µg/ml; (ii) anti-phosphotyrosine mAb PY99, 1 µg/ml; (iii) anti-phosphotyrosine antiserum, 2 µg/ml; (iv) anti-p56lck mAb, 1 µg/ml; (v) anti-p59fyn mAb, 1 µg/ml. Then, the membrane was incubated in TBS with 0.5% Tween 20 and 2.5% (w/v) fatty acid-free milk powder three times for 10 min. Subsequently, horseradish peroxidase-labeled goat anti-mouse antiserum (Dianova, Hamburg, Germany) was added (dilution in TBS with 0.5% Tween 20 and 2.5% (w/v) fatty acid-free milk powder as recommended by the manufacturer, e.g. 1:2000 to 1:10,000) for 1 h at room temperature. Then, the following washing procedure was carried out with the membrane: two times briefly with TBS, two times for 10 min in TBS with 0.5% Tween 20, for 10 min in TBS with 3% Tween 20, two times for 15 min in TBS with 0.5% Tween 20, two times for 30 min in TBS with 0.5% Tween 20, and two times for 30 min in TBS alone. Finally, the blots were developed using the ECL kit (Amersham Pharmacia Biotech) according to the manufacturer's instructions.

In Vitro Tyrosine Phosphorylation of RyR-- P10 membranes were prepared from unstimulated Jurkat T cells as described above. The membrane pellet was resuspended in kinase buffer (20 mM MOPS, pH 7.0, 5 mM MgCl2, 5 mM MnCl2, 150 mM NaCl) at 10 mg of protein/ml, and 500 µl of the suspension were incubated with 1 µg of recombinant GST-p56lck or GST-p59fyn (20) in the presence of 1 mM ATP at 37 °C. To terminate the incubation, protein samples (100 µl) were removed and rapidly frozen in liquid nitrogen. The samples were then solubilized (0.25% CHAPS, w/v) and subjected to immunoprecipitation using anti-RyRcommon mAb (Calbiochem) and SDS-PAGE in a 6% gel (3% stacking gel) under reducing conditions. Western blotting using anti-Tyr(P) mAb (PY99) was carried out as described above.

Ca2+ Release Assay in Permeabilized Jurkat T Cells-- Jurkat T cells were permeabilized as described (21) with the following modifications: saponin concentration (final) 40 µg/ml, incubation period with saponin 17.5 or 20 min.

Measurements with 900 µl of cell suspension (containing ~1.2 × 107 permeabilized cells) in the presence of 1 µM fura2/free acid were carried out in standard quartz fluorescence cuvettes and were started by addition of creatine kinase (20 units/ml final concentration) and creatine phosphate (20 mM final concentration). Fluorescence was recorded in a Hitachi F2000 instrument with wavelength settings of 340 and 380 nm for excitation (alternating) and 495 nm for emission.

Subsequent addition of ATP (1 mM final concentration) completed uptake of Ca2+ ions into stores, and the resulting basal Ca2+ concentration was usually between 100 and 500 nM, depending on the individual preparation. At the beginning of each series of experiments, the quality of the permeabilized cell preparation was checked by its responsiveness to Ins(1,4,5)P3 (4 µM final concentration) and cADPR (10 µM final concentration). Chelex resin (Sigma) was added generally to reagent solutions, e.g. cADPR, Ins(1,4,5)P3, GST fusion proteins, to remove contaminations of Ca2+.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Jurkat T lymphocytes express the RyR as shown by immunoprecipitation and Western blotting (Fig. 1A), and confocal microscopy (Fig. 1B). The amount of RyR detected by an anti-RyRcommon mAb did not change significantly within the first minutes upon stimulation of the TCR/CD3 complex (Fig. 1A). When 10,000 × g membranes were prepared in the presence of the Tyr phosphatase inhibitor dephostatin (100 µM), a transient phosphorylation of Tyr residues of the RyR in response to stimulation of the TCR/CD3 complex was observed (Fig. 1A).


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 1.   Tyrosine phosphorylation of the RyR in response to stimulation of the TCR/CD3 complex. Jurkat T lymphocytes were stimulated by anti-CD3 mAb OKT3 (10 µg/ml) for the times indicated (A and C), the cells were homogenized, and P10 membranes were prepared in the presence of dephostatin (100 µM) as described under "Experimental Procedures." P10 membranes were solubilized in lysis buffer (25 mM HEPES, pH 7.2, 150 mM NaCl, 0.25% CHAPS (w/v), 500 µM AEBSF, 20 µM leupeptin, 1 µM pepstatin, 10 µM antipain), immunoprecipitated with anti-RyRcommon polyclonal antiserum and separated by SDS-PAGE (3% stacking gel, 6% separation gel). The mass of protein in individual lanes corresponds to the mass of RyR immunoprecipitated by 4 µg of anti-RyRcommon polyclonal antiserum in case of anti-RyR Western blot (A, three lanes on the left side; C, five lanes on the right side) and to 1 µg of anti-RyRcommon polyclonal antiserum in case of anti-phosphotyrosine Western blot (A, three lanes on the right side; C, five lanes on the left side). Subsequent tank blotting and immunostaining were carried out as described under "Experimental Procedures." Antibodies used for immunostaining: A, anti-RyRcommon mAb (Calbiochem) and anti-phosphotyrosine rabbit polyclonal antiserum (Upstate Biotechnology); C, anti-RyRcommon mAb (Calbiochem) and anti-phosphotyrosine PY 99 (Santa Cruz). B, confocal microscopy was carried out as described under "Experimental Procedures" using cells fixed with p-formaldehyde and permeabilized by methanol. Anti-RyRcommon mAb (Calbiochem) was used as primary and fluorescein isothiocyanate-labeled goat anti-mouse antiserum as secondary antibody. Raw images were obtained at 100-fold magnification, and confocal images were calculated using the point-spread algorithm. For comparison, the bright field image of the cell is shown in the upper part of B.

Using anti-RyRcommon mAb and a fluorescein isothiocyanate-labeled goat anti-mouse antiserum as secondary antibody in confocal microscopy, the main localization of the RyR was found to be close to the plasma membrane in permeabilized Jurkat cells (Fig. 1B). In intact cells, no staining was observed (data not shown). Similar results were obtained using 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-ryanodine (Molecular Probes) for staining (data not shown). These results indicate that RyR are localized within membrane systems close to the inner surface of the plasma membrane.

Phosphorylation of Tyr residues of the RyR was transient, showing marked phosphorylation at 2 min (Fig. 1A). A more detailed analysis of the time course revealed very weak phosphorylation by 15 and 30 s, whereas substantial phosphorylation was observed at 1 and 2 min (Fig. 1C). At later time points, e.g. 5 min (Fig. 1A) or 10 or 20 min (data not shown), no phosphorylation on Tyr residues could be detected. These results were obtained with two different anti-phospho-Tyr antibodies, the mAb PY99 (Santa Cruz Biotechnology) and a polyclonal anti-phosphotyrosine antiserum (rabbit polyclonal IgG; Upstate Biotechnology).

Membrane distribution of RyR, taken together with an extremely rapid kinetics of its tyrosine phosphorylation following TCR/CD3 ligation, implicated p59fyn and p56lck in this event. These PTKs are localized to the membrane due to their N-terminal myristoylation (22, 23) and palmitoylation (24, 25); are constitutively associated with the intracellular domains of several surface proteins, including TCR/CD3 (p59fyn) and CD4 (p56lck) (26, 27); and respond very rapidly to TCR/CD3 stimulation (12, 28). Therefore, p59fyn and p56lck are candidates to be involved in Tyr phosphorylation of the RyR.

To identify PTK(s) phosphorylating RyR in Jurkat T cells, co-immunoprecipitation experiments using anti-RyR antiserum were carried out (Fig. 2). In addition to tyrosine phosphorylation of the RyR (Fig. 2, left panel, 2-min time point), marked Tyr phosphorylation of a band (or a double band) near 55-60 kDa was detected in RyR immunoprecipitates (Fig. 2, left panel). The time course of phosphorylation of this band/double band was more rapid as compared with Tyr phosphorylation of the RyR itself (Fig. 2, left panel), thus being consistent with the idea that this band represents the PTK(s) associated with and phosphorylating RyR. Analysis of RyR immunoprecipitates for individual PTKs demonstrated that p59fyn and p56lck were associated with RyR in Jurkat T cells. Interestingly, p59fyn was not found in RyR immunoprecipitate from unstimulated cells, but was co-precipitated in a time- and stimulation-dependent fashion (Fig. 2, middle panel). The same experiment carried out for p56lck showed co-immunoprecipitation at all time points, regardless of whether the cells had been stimulated or not (Fig. 2, right panel).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 2.   Tyrosine phosphorylation of p56lck and p59fyn co-immunoprecipitated with the RyR. Jurkat T cells were stimulated as indicated by OKT3 (10 µg/ml). Homogenization, preparation, and solubilization of P10 membranes and immunoprecipitation using anti-RyRcommon polyclonal antiserum were carried out as described in Fig. 1. Protein was separated by SDS-PAGE (7.5% separation gel, 3% stacking gel). The mass of protein in individual lanes corresponds to the mass of RyR immunoprecipitated by 1 µg of anti-RyRcommon polyclonal antiserum. Subsequent tank blotting and immunostaining were carried out as described under "Experimental Procedures." Antibodies used for immunostaining: left panel, anti-phosphotyrosine mAb PY 99, middle panel, anti-p59fyn mAb; right panel, anti-p56lck mAb (all from Santa Cruz). Since the signal with anti-p56lck was more intense as compared with mAb PY 99 or anti-p59fyn, the exposure time of the anti-p56lck blot (right panel) was shortened. This shorter exposure time explains the lack of (artificial) "staining" of the lower edge of the blot.

The PTKs implicated in RyR tyrosine phosphorylation, p56lck and p59fyn, were then expressed as GST fusion proteins and tested for the ability to phosphorylate RyR in vitro. GST-p59fyn and GST-p56lck both stimulated marked phosphorylation on tyrosine residues of RyR (Fig. 3). In these experiments P10 membranes were incubated with the GST kinases in the presence of ATP. Interestingly, the phosphorylation was not transient, as observed in vivo (Fig. 1), but was stable for at least 20 min. This indicates loss or inhibition of phosphotyrosine-protein phosphatase(s) in the P10 preparation on the one hand (kinase assay), or loss of direct contact of PTKs and RyR during spatial redistribution in vivo.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   In vitro phosphorylation of the RyR by GST-p59fyn and GST-p56lck. P10 membranes from unstimulated Jurkat T cells were resuspended in kinase buffer (20 mM MOPS, pH 7.0, 5 mM MgCl2, 5 mM MnCl2, 150 mM NaCl). Recombinant GST-p59fyn and GST- p56lck (each 1 µg) were incubated with P10 membranes (5 mg of protein) in the presence of 1 mM ATP for the times indicated. Incubations were stopped by freezing samples of 1 mg of protein in liquid nitrogen. Then, the membranes were solubilized, RyR was immunoprecipitated, and the immunoprecipitates were subjected to SDS-PAGE (3% stacking gel, 6% separation gel; 5 µg of protein/lane). Tank blotting and immunostaining using anti-phosphotyrosine mAb PY 99 were carried out as described under "Experimental Procedures."

Jayaraman et al. (16) have reported that tyrosine phosphorylation of the type 1 InsP3 receptor by p59fyn in the presence of Ins(1,4,5)P3 resulted in enhanced channel opening as measured by single-channel recordings in lipid planar bilayers. Using permeabilized Jurkat T cells, a well established model to analyze Ca2+ release by Ins(1,4,5)P3 and cADPR (18, 29), addition of GST-p59fyn, additional GST fusion proteins, or GST alone prior to addition of cADPR did not have significant effects on the amplitude of cADPR-mediated Ca2+-release (Fig. 4, left panel). In addition, the sensitivity of the permeabilized T cells to different concentrations of cADPR (0.1 to 10 µM) remained essentially unchanged with prior addition of GST-p59fyn (data not shown); in other words, there was no shift in the concentration-response curve for cADPR. Next, we added GST-p59fyn a few minutes later than cADPR, a time point where the response to cADPR was still highly active (Fig. 4, middle panel). Under these conditions, GST-p59fyn concentration-dependently evoked additional Ca2+ release. Importantly, GST-p56lck, GST-Grb2, or GST alone used as controls only very slightly increased cADPR-mediated Ca2+ release under these conditions (Fig. 4, right panel). The effect of GST-p59fyn was due to its catalytic activity because addition of the tyrosine kinase inhibitor PP2 1 min before addition of GST-p59fyn concentration-dependently blocked the enhancing effect of GST-p59fyn without disturbing the effect of cADPR itself (Table I). Interestingly, cADPR could be substituted completely by 4-chloro-3-ethylphenol (4-CEP, Ref. 30) and partially by Ca2+ ions, known agonists of RyR. Ca2+ release activated by 4-CEP and Ca2+ was significantly enhanced by GST-p59fyn (Table II), indicating that the conformational change induced by RyR channel opening might be sufficient to make regulatory tyrosine residues accessible to GST-p59fyn.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   GST-p59fyn enhanced cADPR-mediated Ca2+ release in permeabilized Jurkat T cells. Jurkat T cells were permeabilized as detailed under "Experimental Procedures." [Ca2+] was measured by ratiometric fluorimetry in the presence of fura2/free acid (1 µM) after reloading of Ca2+ stores by addition of creatine kinase, creatine phosphate, and ATP. Left panel shows representative tracings obtained with additions of GST or GST fusion proteins (2 µg each) followed by cADPR (10 µM); the bar chart below is the data summary as mean ± S.E. (n = 3). Middle panel represents the concentration-response curve for the enhancing effect of GST-p59fyn when added after cADPR; data in the lower part are mean ± S.E. (n = 3-5). In the the right panel, additional GST fusion proteins or GST alone (each 2 µg) were added as indicated; the bar chart represents mean values ± S.E. (n = 5-8).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Tyrosine kinase inhibitor PP2 inhibits the effect of GST-p59fyn
[Ca2+] was measured in permeabilized Jurkat T cells by ratiometric fluorimetry in the presence of fura2/free acid (1 µM) as described under "Experimental Procedures." The experiments described here are identical to those in Fig. 4 (middle panel) using 2 µg of GST-p59fyn to enhance the cADPR-mediated Ca2+ release, except that the tyrosine kinase inhibitor PP2 was added 1 min after cADPR, but 1 min before GST-p59fyn.

                              
View this table:
[in this window]
[in a new window]
 
Table II
GST-p59fyn enhanced Ca2+ release stimulated by RyR agonists
[Ca2+] was measured in permeabilized Jurkat T cells by ratiometric fluorimetry in the presence of fura2/free acid (1 µM) as described under "Experimental Procedures." Initial Ca2+ release via RyR was activated by cADPR (10 µM), 4-CEP (500 µM), or addition of CaCl2 (720 nM). One minute later 2 µg of GST-p59fyn was added. Data are Ca2+ increases subsequent to GST-p59fyn addition, expressed as percentage of the effect obtained with GST-p59fyn subsequently to cADPR as initial Ca2+ releasing agent.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In the present study we have shown that (i) the RyR of T cells is localized in intracellular membrane systems close to the plasma membrane, (ii) the RyR was transiently phosphorylated on Tyr residues upon stimulation of the TCR/CD3 complex, (iii) p59fyn and p56lck were detected in co-immunoprecipitates of the RyR, (iv) recombinant GST fusion proteins of p59fyn and p56lck both phosphorylated immunoprecipitated RyR on tyrosine residues in vitro, and (v) GST-p59fyn, but not GST-p56lck, GST-Grb2, or GST alone, enhanced Ca2+ release by cADPR.

Although phosphorylation on tyrosine residues has not yet been demonstrated for RyR, there are several reports on phosphorylation of serine and threonine residues. The type 1 RyR was phosphorylated in vitro by protein kinase A and Ca2+/calmodulin-dependent protein kinase, resulting in functional recovery of the channel, which was inhibited by 2.6 mM Mg2+ (31). Similarly, Ser/Thr phosphorylation also enhanced the sensitivity of the type 1 RyR toward Ca2+ and ATP (32). The type 2 RyR was phosphorylated by exogenously added protein kinase A, Ca2+/calmodulin-dependent protein kinase, and cyclic GMP-dependent protein kinase. However, the Ca2+/calmodulin-dependent protein kinase was much more effective than the other kinases; additionally, endogenous Ca2+/calmodulin-dependent protein kinase appears to associate firmly with the type 2 RyR (33). Type 2 RyR phosphorylation by protein kinase A dissociated FK506-binding protein 12.6 from the channel complex, leading to enhanced channel opening; importantly, it has been shown in failing hearts that the type 2 RyR is hyperphosphorylated by protein kinase A, leading to markedly increased channel opening (34). Pancreatic beta -cells also express the type 2 RyR; in those cells activation of protein kinase A enhanced activation of RyR by caffeine, 4-chloro-3-ethylphenol, or 3,9-dimethylxanthine (30). Importantly, [3H]ryanodine binding was also found to be stimulated by phosphorylation of the brain type (type 3) RyR (35).

Analysis of the type 3 RyR amino acid sequence reveals that multiple tyrosine residues, such as tyrosines 810, 1022, 2289, 4045, and 4684, could well be targeted by Src family PTKs, based on the substrate specificity of these kinases (36). Among the potential substrate sites, tyrosines 4045 and 4684 are also good candidates for binding to Src homology 2 domains of Src family PTKs, based on the specificity of phosphotyrosine sequences recognized by various Src homology 2 domains (37).

The observed p56lck/p59fyn-mediated tyrosine phosphorylation of RyR is consistent with the notion of the central role of these PTKs in early events of T cell signaling. p59fyn and p56lck are thought to trigger the signal transduction pathways initiated by TCR/CD3 ligation by phosphorylating cytoplasmic domains of the TCR/CD3 complex and activating other PTKs involved in these events (38, 39). These PTKs, in turn, phosphorylate phospholipase C-gamma and linker for activation of T cells, thus triggering one pathway of Ca2+ mobilization in T cells (38, 39). Furthermore, it has been shown that p59fyn and p56lck can phosphorylate phospholipase C-gamma directly in vitro (40). Therefore, p59fyn and p56lck play a crucial role in Ca2+ mobilization in T cells. The tyrosine phosphorylation of RyR described in this report may represent another mechanism by which p59fyn affects Ca2+ concentrations in T cells in vivo. Interestingly, tyrosine phosphorylation of RyR at the 2-min time point was in the same order of magnitude as compared with the band likely representing p59fyn (Fig. 2, left panel). It is difficult to relate these relative staining intensities to the proportion of RyR that are actually tyrosine-phosphorylated. However, even a smaller fraction of tyrosine-phosphorylated RyR may in fact be sufficient to act as a triggering system for Ca2+-induced Ca2+-release, thereby also engaging non-phosphorylated RyR. Thus, such a model is well compatible with a functional role of a tyrosine-phosphorylated subfraction of RyR during TCR/CD3-mediated Ca2+ signaling.

Marks and colleagues (16) have shown recently that the type 1 Ins(1,4,5)P3 receptor is tyrosine-phosphorylated in Jurkat T cells upon stimulation of the TCR/CD3 complex. In addition, they could show that this phosphorylation increased the open probability of the isolated Ins(1,4,5)P3 receptor as measured in lipid planar bilayer experiments (16). To investigate a possible similar influence of tyrosine phosphorylation of the RyR of T cells, we have used permeabilized Jurkat T cells (29). In such permeabilized cells, recombinant GST-p59fyn, but not GST-p56lck, GST-Grb2, or GST alone, concentration-dependently and specifically enhanced cADPR-mediated Ca2+ release in the presence of ATP and an ATP-regenerating system. Surprisingly, this effect required initial activation of RyR by cADPR. This activation changed two parameters of the system; first, [Ca2+] was elevated, and second, the RyR Ca2+ channels switched to the open conformation. Thus, one possible explanation would be that an elevated Ca2+ concentration alone is sufficient for the catalytic effect of GST-p59fyn on RyR. However, GST-p59fyn does not require Ca2+ ions for its catalytic activity. On the other hand, it is well demonstrated that Ca2+ ions act as agonists at the RyR and thereby induce a conformational change of the RyR/Ca2+ channel, as visualized by cryo-electron microscopy and subsequent image processing techniques (41). This view is supported by the finding that activation of RyR by the agonists 4-CEP and Ca2+ was enhanced by GST-p59fyn in a similar way as for cADPR. Thus, conformational changes are very likely to result from binding of these three ligands (this statement does not necessary imply that cADPR binds directly to RyR; additional proteins may be involved here). A similar observation was made when the enhancement of Ins(1,4,5)P3 stimulation of the type 1 Ins(1,4,5)P3 receptor from T cells by p59fyn was measured in bilayer experiments. In that case, the effect was observed only at high [Ca2+] at the cytosolic side, indicating a similar Ca2+-mediated conformational change of the type 1 InsP3 receptor (16). Taken together, these data indicate that the tyrosine residue(s) that could theoretically be phosphorylated by GST-p59fyn are not accessible when the RyR Ca2+ channel is in the closed conformation.

In conclusion, we have shown transient tyrosine phosphorylation of the RyR of T cells in response to stimulation of the TCR/CD3 complex. In addition, in permeabilized cells Ca2+ release by cADPR and 4-CEP were significantly enhanced by GST-p59fyn. Our demonstration that the effect of GST-p59fyn was specific, concentration-dependent, and could be inhibited by the tyrosine kinase inhibitor PP2 provides strong evidence that tyrosine phosphorylation of RyR may play a crucial role in the early phase of T cell Ca2+ signaling and thereby may constitute an additional element of fine tuning of T lymphocyte Ca2+ signaling. In a broader context, our data provide first evidence that, in addition to serine/threonine protein kinases, PTKs are also involved in regulation of RyR.

    FOOTNOTES

* This work was supported by Deutsche Forschungsgemeinschaft Grants Gu 360/2-4 and Gu 360/2-5 (to A. H. G. and G. W. M.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed. Tel.: 49-40-42803-2828; Fax: 49-40-42803-9880; E-mail: guse@uke.uni-hamburg.de.

Published, JBC Papers in Press, July 20, 2001, DOI 10.1074/jbc.M100715200

    ABBREVIATIONS

The abbreviations used are: RyR, ryanodine receptor(s); [Ca2+]i, intracellular free Ca2+ concentration; cADPR, cyclic adenosine diphosphoribose; 4-CEP, 4-chloro-3-ethylphenol; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; GST, glutathione S-transferase; Ins(1, 4,5)P3, D-myo-inositol 1,4,5-trisphosphate; mAb, monoclonal antibody; MOPS, 4-morpholinepropanesulfonic acid; PAGE, polyacrylamide gel electrophoresis; PTK, protein-tyrosine kinase(s); TBS, Tris-buffered saline; TCR/CD3, T cell receptor/CD3.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Sutko, J. L., and Airey, J. A. (1996) Physiol. Rev. 76, 1027-1071
2. Giannini, G., Conti, A., Mammarella, S., Scrobogna, M., and Sorrentino, V. (1995) J. Cell Biol. 128, 893-904
3. Marks, A. R. (1997) Am. J. Physiol. 272, H597-H605
4. Reyes-Harde, M., Empson, R., Potter, B. V. L., Galione, A., and Stanton, P. K. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 4061-4066
5. Endo, M., Tanaka, M., and Ogawa, Y. (1970) Nature 228, 34-36
6. Lee, H. C. (1997) Physiol. Rev. 77, 1133-1164
7. Guse, A. H. (1999) Cell. Signal. 5, 309-316
8. Guse, A. H. (1998) Crit. Rev. Immunol. 18, 419-448
9. Premack, B. A., and Gardner, P. (1992) Am. J. Physiol. 263, C1119-C1140
10. Timmerman, L. A., Clipstone, N. A., Ho, S. N., Northrop, J. P., and Crabtree, G. R. (1996) Nature 383, 837-840
11. Appleby, M. W., Gross, J. A., Cooke, M. P., Levin, S. D., Qian, X., and Perlmutter, R. M. (1992) Cell 70, 751-763
12. Burkhardt, A. L., Stealey, B., Rowley, R. B., Mahajan, S., Prendergast, M., Fargnoli, J., and Bolen, J. B. (1994) J. Biol. Chem. 269, 23642-23647
13. Stein, P. L., Lee, H. M., Rich, S., and Soriano, P. (1992) Cell 70, 741-750
14. Straus, D. B., and Weiss, A. (1992) Cell 70, 585-593
15. Guse, A. H., da Silva, C. P., Berg, I., Weber, K., Heyer, P., Hohenegger, M., Ashamu, G. A., Skapenko, A. L., Schulze-Koops, H., Potter, B. V. L., and Mayr, G. W. (1999) Nature 398, 70-73
16. Jayaraman, T., Ondrias, K., Ondriasova, E., and Marks, A. R. (1996) Science 272, 1492-1494
17. Salazar, E. P., and Rozengurt, E. (1999) J. Biol. Chem. 274, 28371-28378
18. Guse, A. H., Roth, E., and Emmrich, F. (1993) Biochem. J. 291, 447-451
19. Atherton, T. J., Wilson, S., Morrey, R. I., and Waterfall, A. (1997) Digital Confocal Imaging: Research Report RR333 , Department of Computer Science, University of Warwick, Coventry, United Kingdom
20. Tsygankov, A. Y., Spana, C., Rowley, R. B., Penhallow, R. C., Burkhardt, A. L., and Bolen, J. B. (1994) J. Biol. Chem. 269, 7792-7800
21. Guse, A. H., Roth, E., and Emmrich, F. (1992) Biochem. J. 288, 489-495
22. Marchildon, G. A., Casnellie, J. E., Walsh, K. A., and Krebs, E. G. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 7679-7682
23. Peters, D. J., McGrew, B. R., Perron, D. C., Liptak, L. M., and Laudano, A. P. (1990) Oncogene 5, 1313-1319
24. Koegl, M., Zlatkine, P., Ley, S. C., Courtneidge, S. A., and Magee, A. I. (1994) Biochem. J. 303, 749-753
25. Paige, L. A., Nadler, M. J. S., Harrison, M. L., Cassady, J. M., and Geahlen, R. L. (1993) J. Biol. Chem. 268, 8669-8674
26. Samelson, L. E., Phillips, A. F., Luong, E. T., and Klausner, R. D. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4358-4362
27. Veillette, A., Bookman, M. A., Horak, E. M., Samelson, L. E., and Bolen, J. B. (1989) Nature 338, 257-259
28. Tsygankov, A. Y., Broker, B. M., Fargnoli, J., Ledbetter, J. A., and Bolen, J. B. (1992) J. Biol. Chem. 267, 18259-18262
29. Guse, A. H., da Silva, C. P., Emmrich, F., Ashamu, G. A., Potter, B. V. L., and Mayr, G. W. (1995) J. Immunol. 155, 3353-3359
30. Islam, M. S., Leibiger, I., Leibiger, B., Rossi, D., Sorrentino, V., Ekström, T. J., Westerblad, H., Andrade, F. H., and Berggren, P. O. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 6145-6150
31. Hain, J., Nath, S., Mayrleitner, M., Fleischer, S., and Schindler, H. (1994) Biophys. J. 67, 1823-1833
32. Herrmann-Frank, A., and Varsanyi, M. (1993) FEBS Lett. 332, 237-242
33. Hohenegger, M., and Suko, J. (1993) Biochem. J. 296, 303-308
34. Marx, S. O, Reiken, S., Hisamatsu, Y., Jayaraman, T., Burkhoff, D., Rosemblit, N., and Marks, A. R. (2000) Cell 101, 365-376
35. McPherson, P. S., and Campbell, K. P. (1993) J. Biol. Chem. 268, 19785-19790
36. Zhou, S., Carraway, K. L. r., Eck, M. J., Harrison, S. C., Feldman, R. A., Mohammadi, M., Schlessinger, J., Hubbard, S. R., Smith, D. P., Eng, C., Lorenzo, M. J., Ponder, B. A. J., Mayer, B. J., and Cantley, L. C. (1995) Nature 373, 536-539
37. Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., King, F., Roberts, T., Ratnofsky, S., Lechleider, R. J., Neel, B. G., Birge, R. B., Fajardo, J. E., Chou, M. M., Hanafusa, H., Schaffhausen, B., and Cantley, L. C. (1993) Cell 72, 767-778
38. van Leeuwen, J. E., and Samelson, L. E. (1999) Curr. Opinion Immunol. 11, 242-248
39. Chan, A. C., and Shaw, A. S. (1996) Curr. Opinion Immunol. 8, 394-401
40. Liao, F., Shin, H. S., and Rhee, S. G. (1993) Biochem. Biophys. Res. Commun. 191, 1028-1033
41. Sharma, M. R., Jeyakumar, L. H., Fleischer, S., and Wagenknecht, T. (2000) J. Biol. Chem. 275, 9485-9491


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
I. Panfoli, S. Ravera, A. Fabiano, R. Magrassi, A. Diaspro, A. Morelli, and I. M. Pepe
Localization of the Cyclic ADP-Ribose-Dependent Calcium Signaling Pathway in Bovine Rod Outer Segments
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 978 - 984.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Zhang, Q. Zhang, A. Tengholm, and A. Sjoholm
Involvement of JAK2 and Src kinase tyrosine phosphorylation in human growth hormone-stimulated increases in cytosolic free Ca2+ and insulin secretion
Am J Physiol Cell Physiol, September 1, 2006; 291(3): C466 - C475.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. T. Duthoit, D. J. Mekala, R. S. Alli, and T. L. Geiger
Uncoupling of IL-2 Signaling from Cell Cycle Progression in Naive CD4+ T Cells by Regulatory CD4+CD25+ T Lymphocytes
J. Immunol., January 1, 2005; 174(1): 155 - 163.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Q. Zhang, M. Kohler, S.-N. Yang, F. Zhang, O. Larsson, and P.-O. Berggren
Growth Hormone Promotes Ca2+-Induced Ca2+ Release in Insulin-Secreting Cells by Ryanodine Receptor Tyrosine Phosphorylation
Mol. Endocrinol., July 1, 2004; 18(7): 1658 - 1669.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Cui, S. J. Matkovich, N. deSouza, S. Li, N. Rosemblit, and A. R. Marks
Regulation of the Type 1 Inositol 1,4,5-Trisphosphate Receptor by Phosphorylation at Tyrosine 353
J. Biol. Chem., April 16, 2004; 279(16): 16311 - 16316.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Kunerth, M. F. Langhorst, N. Schwarzmann, X. Gu, L. Huang, Z. Yang, L. Zhang, S. J. Mills, L.-h. Zhang, B. V.L. Potter, et al.
Amplification and propagation of pacemaker Ca2+ signals by cyclic ADP-ribose and the type 3 ryanodine receptor in T cells
J. Cell Sci., April 15, 2004; 117(10): 2141 - 2149.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Schwarzmann, S. Kunerth, K. Weber, G. W. Mayr, and A. H. Guse
Knock-down of the Type 3 Ryanodine Receptor Impairs Sustained Ca2+ Signaling via the T Cell Receptor/CD3 Complex
J. Biol. Chem., December 20, 2002; 277(52): 50636 - 50642.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/37/34722    most recent
M100715200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guse, A. H.
Right arrow Articles by Mayr, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guse, A. H.
Right arrow Articles by Mayr, G. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.